Elizabeth Gordon
Consigliere Generale presso Excaliard Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Elizabeth Gordon
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Elizabeth Gordon tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Theregen, Inc.
 Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Smith + Nephew, Inc.
 Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Medical Specialties | Corporate Officer/Principal | |
Genetrix, Inc.
 Genetrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Genetrix, Inc. is a genetics testing research company. The company is based in Scottsdale, AZ. Genetrix was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on May 06, 1996 for $39.20 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Oregon Health & Science University | College/University | Doctorate Degree | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Corporate Officer/Principal | |
| Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline AG
 GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a company based in Munchenbuchsee, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Founder | |
| Chori Pars AB | Chief Executive Officer | ||
| National Center for Biotechnology Information | General Government | Corporate Officer/Principal | |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Consultant / Advisor | |
| Centers for Therapeutic Innovation | Founder | ||
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman Chairman Director/Board Member | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
Codagenix, Inc.
 Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | Medical/Nursing Services | Chairman Director/Board Member | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
January Therapeutics, Inc.
 January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Chief Executive Officer | |
Sorriso Pharmaceuticals, Inc.
 Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Chairman Director/Board Member | |
| New Enterprise Associates, Inc. | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 31 |
| Svezia | 10 |
| Regno Unito | 6 |
| Spagna | 3 |
| Svizzera | 3 |
Settori
| Health Technology | 32 |
| Commercial Services | 8 |
| Consumer Services | 7 |
| Government | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 136 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 39 |
| Chief Executive Officer | 23 |
| Chief Tech/Sci/R&D Officer | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Michael Grey | 32 |
| Carl Johan Kördel | 31 |
| Maha Katabi | 28 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
| Paul Grint | 22 |
| Michael Hodges | 20 |
| Alan Fuhrman | 17 |
| Mitchell Mutz | 16 |
| Chris LeMasters | 15 |
| Jill Howe | 10 |
| Gary D. Gentzkow | 7 |
| Karen Joy Shaw | 4 |
| Tim Xu | 2 |
- Borsa valori
- Insiders
- Elizabeth Gordon
- Connessioni Società
